Close Menu
Finletix
  • Home
  • AI
  • Financial
  • Investments
  • Small Business
  • Stocks
  • Tech
  • Marketing
What's Hot

Nvidia’s AI empire: A look at its top startup investments

October 12, 2025

I Used ChatGPT to Plan a Trip to Tunisia, While My Partner Used Claude

October 12, 2025

I Turned Down NYU for a Debt-Free Community College Path

October 12, 2025
Facebook X (Twitter) Instagram
Facebook X (Twitter) Instagram
Finletix
  • Home
  • AI
  • Financial
  • Investments
  • Small Business
  • Stocks
  • Tech
  • Marketing
Finletix
Home » Stocks Wednesday from analyst calls: Nvidia, Apple and more
Investments

Stocks Wednesday from analyst calls: Nvidia, Apple and more

arthursheikin@gmail.comBy arthursheikin@gmail.comAugust 27, 2025No Comments5 Mins Read
Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
Share
Facebook Twitter LinkedIn Pinterest Email

[ad_1]

Here are Wednesday’s biggest calls on Wall Street: Cantor Fitzgerald initiates CoreWeave as buy Cantor said it is bullish on shares of CoreWeave. “We believe CoreWeave should benefit from secular growth trends in AI, specifically large language model (LLM) training and inference based usage, as an enabling software-driven AI-focused hyperscaler, comfort in near-term demand/supply imbalance, and competitive differentiation.” Read more. Goldman Sachs downgrades Deutsche Bank to neutral from buy Goldman Sachs downgraded the German banking giant mainly on valuation. “However, given the recent rally in the share price, Deutsche Bank now trades at a P/E multiple which is roughly in line with our broader coverage — at 10x our 2025E EPS estimate, and 9x 2026E.” Read more. Wells Fargo reiterates Nvidia as overweight Wells Fargo said it is sticking with the stock heading into earnings on Wednesday after the bell. “Our Overweight rating is based on our positive stance on NVIDIA’s competitive positioning in gaming GPUs and expanding growth opportunities in data center, HPC [high performance computing], and emerging / expanding AI opportunities.” Piper Sandler initiates Inventiva as overweight Piper Sandler said shares of the biotech company are well positioned. “We are initiating on Inventiva SA (IVA) with an Overweight rating and $26 PT.” Goldman Sachs reiterates Apple as buy Goldman Sachs said it is bullish ahead of Apple’s product event on Sept. 9. “Though in the past AAPL’s September event has had nominal impacts on day-of stock price performance, we are encouraged by reports surrounding (1) form factor updates to iPhone 17 models (17 ‘Air’ model, larger base screen size); (2) the potential for a price increase to the iPhone 17 Pro…” Loop reiterates DoorDash as buy Loop called DoorDash a “category killer.” “While valuation leads gig-economy peers and the stock is not cheap, we think that with superior growth, considerable earnings power beneath ongoing investment, open ended opportunity and best-in-class management, a premium is warranted. Reiterate Buy and $305 PT.” KeyBanc initiates Mach Natural Resources as overweight KeyBanc said the natural resources company is well positioned. “We initiate coverage of Mach Natural Resources LP with an OW rating and an $18 PT.” JPMorgan downgrades Krispy Kreme to underweight from neutral JPMorgan said it sees “limited visibility” of a turnaround plan. “We are downgrading Krispy Kreme shares to Underweight from Neutral and continue to not publish a price target.” Bank of America upgrades Vir to buy from neutral Bank of America said it is bullish on the biotech company’s treatment for liver disease. “We are upgrading Vir to Buy from Neutral and raising our PO to $14 from $12 as we think the market is underestimating the potential for its asset for treatment of severe liver disease caused by hepatitis delta virus.” JPMorgan upgrades Televisa to overweight from neutral JPMorgan upgraded the LatAm media company and said it is well positioned for growth. “We upgrade Televisa to Overweight from Neutral, mostly on a more constructive view on its media asset (a 45% stake in TelevisaUnivision), as it has successfully started to generate cash and deleverage, while growing at a quicker pace than its key US peers…” Jefferies reiterates Ralph Lauren as buy Jefferies said the stock is well positioned for a Taylor Swift-Travis Kelce engagement. “Swift is no stranger to the brand, having been mentioned on RL earnings calls for wearing Ralph Lauren for over two years. Swift even wore Ralph Lauren for the cover photo for Time person of the year in 2023. We see this as an encouraging catalyst for the brand, especially ahead of Swift’s upcoming album release in early October and the start of football season for Kelce.” HSBC upgrades Amer Sports to buy from hold HSBC said in its upgrade of Amer that it sees another “leg of growth” for the sporting goods company. “After being on the sidelines for a while following our downgrade late last year, we are again becoming constructive on the name.” Read more. HSBC upgrades Eli Lilly to neutral from reduce The firm said the “bear case has played out” for the stock. “That said, Lilly’s move to increase the prices outside the US sends a clear signal that the company might remain price disciplined.” CLSA initiates Micron as outperform CLSA said Micron is “riding the crest of the AI wave.” “Micron is well-positioned to capitalise on the demand for high bandwidth memory (HBM) from AI customers and to benefit from the healthy demand-supply balance in DRAM in 2H25-2026.” Wedbush initiates Serve Robotics as outperform Wedbush said the autonomous company is “uniquely positioned to capitalize on the accelerating adoption of AI-driven last mile delivery vehicles.” “We are initiating coverage on Serve Robotics with an OUTPERFORM rating and a $15 price target. In our view, Serve Robotics has established a pioneering autonomous delivery platform that is uniquely positioned to capitalize on the accelerating adoption of AI-driven last mile delivery vehicles.” Mizuho initiates Phreesia as outperform Mizuho said shares of the patient management software company have plenty more room to run. “We initiate coverage of PHR with an Outperform rating and $36 PT. Phreesia is a leader in Patient Intake Management software for practitioners.”

[ad_2]

Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
Previous ArticleOne notable trader thinks Nvidia could disappoint
Next Article JPMorgan downgrades Krispy Kreme to underweight
arthursheikin@gmail.com
  • Website

Related Posts

These stocks reporting next week have a history of posting earnings beats and rallying

October 11, 2025

These stocks are now oversold after Trump tariff threat sparks sell-off

October 11, 2025

The stock market is diving on Trump’s threat of more China tariffs. Is this a good time to buy?

October 10, 2025
Add A Comment
Leave A Reply Cancel Reply

Top Posts

Intel cuts 15% of its staff as it pushes to make a comeback

July 24, 2025

Tesla’s stock is tumbling after Elon Musk failure to shift the narrative

July 24, 2025

Women will soon be able to request a female Uber driver in these US cities

July 24, 2025

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Welcome to Finletix — Your Insight Hub for Smarter Financial Decisions

At Finletix, we’re dedicated to delivering clear, actionable, and timely insights across the financial landscape. Whether you’re an investor tracking market trends, a small business owner navigating economic shifts, or a tech enthusiast exploring AI’s role in finance — Finletix is your go-to resource.

Facebook X (Twitter) Instagram Pinterest YouTube
Top Insights

French companies’ borrowing costs fall below government’s as debt fears intensify

September 14, 2025

The Digital Dollar Dilemma: Why Central Banks Are Rushing to Create Digital Currencies

September 1, 2025

FCA opens investigation into Drax annual reports

August 28, 2025
Get Informed

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

© 2026 finletix. Designed by finletix.
  • Home
  • About Us
  • Advertise With Us
  • Contact Us
  • DMCA
  • Privacy Policy
  • Terms and Conditions

Type above and press Enter to search. Press Esc to cancel.